|
|
(Transportation-News.com, March 18, 2017 ) According to Publisher, the Global Auto Injectors Market is accounted for $1.10 billion in 2015 and is expected to reach $3.78 billion by 2022 growing at a CAGR of 19.42%. As large number of patients are opting for self administered treatment and care there is a flawless increase in use of Auto Injectors. Moreover, the high prevailing patients of anaphylaxis had presented a huge demand for the market which seems as pertaining factor behind the market growth. At the same time high cost and need for utmost care are some of the factors hampering the market.
According to Publisher, the Global Auto Injectors Market is accounted for $1.10 billion in 2015 and is expected to reach $3.78 billion by 2022 growing at a CAGR of 19.42%. As large number of patients are opting for self administered treatment and care there is a flawless increase in use of Auto Injectors. Moreover, the high prevailing patients of anaphylaxis had presented a huge demand for the market which seems as pertaining factor behind the market growth. At the same time high cost and need for utmost care are some of the factors hampering the market.
For more information at http://www.reportsweb.com/auto-injectors-global-market-outlook-2015-2022 .
Some of the major key players of the market are Unilife Corporation, Novartis International AG, Becton, Dickinson and Company, Antares Pharma, Inc., Mylan, Inc., Adamis Pharmaceuticals Corp, Hospira Inc, Scandinavian Health Limited (SHL) Group, Sanofi SA, Itelliject Inc , Pfizer, Inc., Lincoln Medical Ltd, Ypsomed Holdings AG, ALK Abello, Teva Pharmaceuticals Ltd and Biogen Idec, Inc.
Devices Covered:
-Smart Autoinjectors
-Product Specific Autoinjectors
-Manual Injection Autoinjectors
-Disposable Autoinjectors
-Reusable Autoinjectors
-Variable Dose Autoinjectors
-Automated Injection Autoinjectors
Product Types Covered:
-Standardized Auto-injectors
-Customized Auto-injectors
Therapeutic Applications covered:
-Autoimmune Diseases
-Anaphylaxis
-Anticoagulants
-Neurology
-Rheumatoid Arthritis
-Infectious Diseases
-Reproductive Health
-Hormones
-Hematopoietics
-Multiple Sclerosis
-Emergency Medicine
-Other Therapeutic Application
Primary Drug Containers Covered:
-Cartridges
-Single Chamber Cartridge
-Dual Chamber Cartridge
-Vials
-Prefilled Syringes
-Plastic Prefilled Syringes
-Glass Prefilled Syringes
Request Sample Copy: http://www.reportsweb.com/inquiry&RW0001322797/sample .
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- Rest of Asia Pacific
- Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt
1 Executive Summary
2 Preface
3 Market Trend Analysis
4 Porters Five Force Analysis
5 Global Auto Injectors Market, By Device
6 Global Auto Injectors Market, By Product Type
7 Global Auto Injectors Market, By Therapeutic Application
8 Global Auto Injectors Market, By Primary Drug Container
9 Global Auto Injectors Market, By Geography
10 Key Developments
11 Company Profiling
11.1 Unilife Corporation
11.2 Novartis International AG
11.3 Becton, Dickinson and Company
11.4 Antares Pharma, Inc.,
11.5 Mylan, Inc.
11.6 Adamis Pharmaceuticals Corp
11.7 Hospira Inc
11.8 Scandinavian Health Limited (SHL) Group
11.9 Sanofi SA
11.10 Itelliject Inc
11.11 Pfizer, Inc.
11.12 Lincoln Medical Ltd
11.13 Ypsomed Holdings AG
11.14 ALK Abello
11.15 Teva Pharmaceuticals Ltd
11.16 Biogen Idec, Inc.
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001322797/buying .
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
